Multimorbidity and statin prescription for primary prevention of cardiovascular diseases: A cross-sectional study in general practice in France

被引:3
|
作者
Onaisi, Racha [1 ]
Dumont, Roxane [2 ]
Hasselgard-Rowe, Jennifer [3 ]
Safar, David [4 ]
Haller, Dagmar M. [5 ]
Maisonneuve, Hubert [5 ]
机构
[1] Univ Bordeaux, Dept Gen Practice, Bordeaux, France
[2] Geneva Univ Hosp, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland
[3] Univ Geneva, Inst Global Hlth, Fac Med, Geneva, Switzerland
[4] Univ Claude Bernard Lyon 1, Univ Coll Gen Med, Lyon, France
[5] Univ Geneva, Univ Inst Primary Care, Fac Med, Geneva, Switzerland
关键词
multimorbidity; cardiovascular diseases; primary prevention; statin; general practice; CLINICAL-PRACTICE; EUROPEAN-SOCIETY; OLDER PATIENTS; CARE; RISK; DEFINITION; GUIDELINES; PHYSICIANS; CARDIOLOGY; PRIORITIES;
D O I
10.3389/fmed.2022.1089050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundStatins are a first line, evidence-based yet underprescribed treatment for cardiovascular primary prevention. In primary care settings, multimorbidity is a complex situation which makes it difficult to apply prevention guidelines. AimTo assess the associations between multimorbidity and prescription of statins in accordance with the 2016 ESC recommendations ("appropriate prescription"), and to identify the factors and conditions associated with these prescriptions. Design and settingCross-sectional prospective study in the French region of Rhone-Alpes among 40 general practitioners and their patients. MethodsWe examined the association between appropriate statin prescription and several patient characteristics, including multimorbidity, using multivariate logistic regression models. ResultsBetween August 2017 and February 2019, 327 patients were included in the study. Seventy-four (22.6%) were on statin medication and 199 (60.9%) exhibited multimorbidity, defined as >= 2 diseases. Only 22.5% of eligible patients were prescribed statins for primary prevention. Diabetes was most strongly associated with appropriate statin prescription (aOR 8.10, CI 95: 3.81-17.80). Multimorbidity was not associated with appropriate statin prescription (aOR 1.31, CI 95: 0.54-3.26), except in the presence of diabetes which defined diabetic multimorbidity (aOR 10.46, CI 95: 4.87-23.35). Conversely, non-diabetic multimorbidity was associated with lower odds of being appropriately prescribed a statin (aOR 0.26, CI 95: 0.12-0.56). ConclusionMultimorbidity, in itself, does not seem to be a determinant factor for appropriate statin prescription. The latter appears to be determined by a patient's type of multimorbidity, especially the presence or not of diabetes. Differentiating between diabetic and non-diabetic multimorbidity may be a pragmatic way for GPs to improve primary prevention in a patient-centered and shared decision-making approach.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study
    Homer, Kate
    Boomla, Kambiz
    Hull, Sally
    Dostal, Isabel
    Mathur, Rohini
    Robson, John
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2015, 65 (637): : E538 - E544
  • [2] Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
    Fleetcroft, Robert
    Schofield, Peter
    Ashworth, Mark
    [J]. BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [3] Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
    Robert Fleetcroft
    Peter Schofield
    Mark Ashworth
    [J]. BMC Health Services Research, 14
  • [4] Satisfaction with general practice care in German patients with multimorbidity: a cross-sectional study
    Mortsiefer, Achim
    Altiner, Attila
    Ernst, Annette
    Kadusziewicz, Hanna
    Krahe, Alice
    Mellert, Christine
    Schaefer, Ingmar
    Stolzenbach, Carl-Otto
    Wiese, Birgitt
    Loeffler, Christin
    [J]. FAMILY PRACTICE, 2017, 34 (04) : 452 - 458
  • [5] Prescription-free consultation: A cross-sectional study in general practice
    Richard, Amelie
    Charuel, Elodie
    Cambier, Sebastien
    Turpin, Manon
    Baudin, Bruno
    Moreno, Jose-Philippe
    Vaillant-Roussel, Helene
    [J]. THERAPIE, 2024, 79 (03):
  • [6] Multimorbidity in Maori and Pacific patients: cross-sectional study in a Dunedin general practice
    Stokes, Tim
    Azam, Mayur
    Noble, Fiona Doolan
    [J]. JOURNAL OF PRIMARY HEALTH CARE, 2018, 10 (01) : 39 - 43
  • [7] Determinants of drug prescription in general practice in Casablanca: Cross-sectional study
    Traore, B.
    Zoukal, S.
    Tsoumbou-Bakana, G.
    Nani, S.
    Hassoune, S.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [8] MUSCULAR SYMPTOMS IN FAMILY PRACTICE PATIENTS WITH OR WITHOUT STATIN PRESCRIPTION - A CROSS-SECTIONAL STUDY
    Mosshammer, D.
    Lorenz, G.
    Meznaric, S.
    Schwarz, J.
    Moerike, K.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 9 - 9
  • [9] Prescription of antitussives in asthma: A cross-sectional study in primary care in France and in Italy
    Darmon, David
    Laforest, Laurent
    Van Ganse, Eric
    Devouassoux, Gilles
    Follet, Alain
    Letrilliart, Laurent
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [10] Chronic care management in Danish general practice - a cross-sectional study of workload and multimorbidity
    Moth, Grete
    Vestergaard, Mogens
    Vedsted, Peter
    [J]. BMC FAMILY PRACTICE, 2012, 13